These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Validation of a double-color ELISpot assay of IFN-γ and IL-4 production in human peripheral blood mononuclear cells. Dapporto F; De Tommaso D; Marrocco C; Piu P; Semplici C; Fantoni G; Ferrigno I; Piccini G; Monti M; Vanni F; Razzano I; Manini I; Montomoli E; Manenti A J Immunol Methods; 2024 Jan; 524():113588. PubMed ID: 38040193 [TBL] [Abstract][Full Text] [Related]
13. The granzyme B and interferon-gamma enzyme-linked immunospot assay as alternatives for cytotoxic T-lymphocyte precursor frequency after renal transplantation. van Besouw NM; Zuijderwijk JM; de Kuiper P; Ijzermans JN; Weimar W; van der Mast BJ Transplantation; 2005 May; 79(9):1062-6. PubMed ID: 15880044 [TBL] [Abstract][Full Text] [Related]
14. T Cell ELISPOT: For the Identification of Specific Cytokine-Secreting T Cells. Leehan KM; Koelsch KA Methods Mol Biol; 2015; 1312():427-34. PubMed ID: 26044024 [TBL] [Abstract][Full Text] [Related]
15. The challenge of measuring elusive immune markers by enzyme-linked immuno-spot (ELISPOT) technique. Faresjö M Methods Mol Biol; 2014; 1172():3-12. PubMed ID: 24908290 [TBL] [Abstract][Full Text] [Related]
16. Harmonization and qualification of an IFN-γ Enzyme-Linked ImmunoSpot assay (ELISPOT) to measure influenza-specific cell-mediated immunity within the FLUCOP consortium. Waerlop G; Leroux-Roels G; Lambe T; Bellamy D; Medaglini D; Pettini E; Cox RJ; Trieu MC; Davies R; Bredholt G; Montomoli E; Gianchecchi E; Clement F Front Immunol; 2022; 13():984642. PubMed ID: 36159843 [TBL] [Abstract][Full Text] [Related]
17. Diagnosis of latent tuberculosis infection in bacille Calmette-Guérin vaccinated subjects in China by interferon-gamma ELISpot assay. Zhang M; Wang H; Liao M; Chen X; Graner M; Zhu X; Zhang J; Yang Q; Lu H; Zhou B; Chen X Int J Tuberc Lung Dis; 2010 Dec; 14(12):1556-63. PubMed ID: 21144240 [TBL] [Abstract][Full Text] [Related]
18. Development of IFN-γ secretory ELISPOT based assay for screening of ADCC responses. Shete A; Suryawanshi P; Chavan C; Kulkarni A; Godbole S; Ghate M; Thakar M J Immunol Methods; 2017 Feb; 441():49-55. PubMed ID: 27923642 [TBL] [Abstract][Full Text] [Related]
19. Proficiency tests to evaluate the impact on assay outcomes of harmonized influenza-specific Intracellular Cytokine Staining (ICS) and IFN-ɣ Enzyme-Linked ImmunoSpot (ELISpot) protocols. Waerlop G; Leroux-Roels G; Pagnon A; Begue S; Salaun B; Janssens M; Medaglini D; Pettini E; Montomoli E; Gianchecchi E; Lambe T; Godfrey L; Bull M; Bellamy D; Amdam H; Bredholt G; Cox RJ; Clement F J Immunol Methods; 2023 Dec; 523():113584. PubMed ID: 37918618 [TBL] [Abstract][Full Text] [Related]
20. Vagaries of the ELISpot assay: specific detection of antigen responsive cells requires purified CD8(+) T cells and MHC class I expressing antigen presenting cell lines. Fuchs YF; Jainta GW; Kühn D; Wilhelm C; Weigelt M; Karasinsky A; Upadhyaya B; Ziegler AG; Bonifacio E Clin Immunol; 2015 Apr; 157(2):216-25. PubMed ID: 25728493 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]